AtriCure (ATRC) Misses Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $34.95 -1.88%
Revenue Growth %: +11.6%
Financial Fact:
Other: -32K
Today's EPS Names:
UBAB, LOAN, FITB, More
Revenue Growth %: +11.6%
Financial Fact:
Other: -32K
Today's EPS Names:
UBAB, LOAN, FITB, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q4 EPS of ($0.30), $0.01 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $73.2 million versus the consensus estimate of $72.39 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The tech crown switches hands: Apple dethrones Nvidia as $4 trillion king
- Autoliv (ALV) Reports In-Line Q2 EPS
- Cantor Fitzgerald Reiterates Overweight Rating on DBV Technologies S.A (DBVT)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
